J. Safra Sarasin Holding AG Has $1.72 Million Stock Holdings in The Clorox Company $CLX

Key Points

• J. Safra Sarasin Holding AG increased its stake in The Clorox Company by 115%, owning 14,300 shares valued at approximately $1.72 million as of the end of the 2nd quarter.
• Clorox reported a quarterly EPS of $2.87, exceeding analyst expectations, and has set FY 2026 guidance at $5.95 to $6.30 EPS.
• The company's quarterly dividend of $1.24 per share will be paid on November 6, with an annualized yield of 4.0%.

J. Safra Sarasin Holding AG grew its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 115.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,300 shares of the company's stock after acquiring an additional 7,648 shares during the period. J. Safra Sarasin Holding AG's holdings in Clorox were worth $1,717,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CLX. Sonora Investment Management Group LLC lifted its holdings in Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock worth $433,000 after purchasing an additional 72 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of Clorox by 0.6% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock worth $1,953,000 after buying an additional 73 shares in the last quarter. Horizon Investments LLC lifted its holdings in shares of Clorox by 4.4% during the first quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock worth $258,000 after buying an additional 75 shares in the last quarter. Sfmg LLC raised its stake in Clorox by 2.8% in the 1st quarter. Sfmg LLC now owns 2,780 shares of the company's stock worth $409,000 after purchasing an additional 76 shares in the last quarter. Finally, Hancock Whitney Corp raised its stake in Clorox by 4.3% in the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company's stock worth $304,000 after purchasing an additional 86 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on CLX shares. Jefferies Financial Group dropped their price objective on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Morgan Stanley dropped their price target on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. TD Cowen dropped their price objective on Clorox from $120.00 to $117.00 and set a "hold" rating for the company in a report on Wednesday. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Clorox in a report on Saturday, September 27th. Finally, Barclays dropped their price target on Clorox from $118.00 to $112.00 and set an "underweight" rating for the company in a research note on Tuesday. One analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Clorox currently has an average rating of "Reduce" and an average price target of $134.08.

Clorox Price Performance

Clorox stock opened at $123.30 on Friday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The stock has a market capitalization of $15.08 billion, a P/E ratio of 18.91, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The stock has a fifty day moving average of $122.81 and a 200-day moving average of $129.64.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox's revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox's dividend payout ratio is currently 76.07%.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the company's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.